NCT02256267View on ClinicalTrials.gov

A Study of LY2835219 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Healthy Volunteers
Interventions
DRUG

LY2835219

Administered orally

DRUG

Rifampin

Administered orally

Trial Locations (1)

75247

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Dallas

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02256267 - A Study of LY2835219 in Healthy Participants | Biotech Hunter | Biotech Hunter